Powered by
ANN ARBOR—The genomics company Genomenon Inc. has announced a partnership with Alexion, a rare disease subsidiary of pharma giant AstraZeneca, that will make critical information needed for the diagnosis and …
ANN-ARBOR—Genomenon, the Ann Arbor-based genetics informatics company, has completed a $5.3 million financing round, company officials announced. They said the financing round in the company. The financing will enable the …
ANN ARBOR—Swift Biosciences, Inc., a developer of DNA and RNA library preparation kits, announced the launch of a new ACE2 Swift Normalase Amplicon Panel to further research on the main …
ANN ARBOR—Swift Biosciences and Arbor Biosciences, two Ann Arbor biotech firms, announced a partnership to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. …
ANN ARBOR—Genomenon, the Ann Arbor genomic search engine provider, announced that the latest release of its Mastermind® Genomic Search Engine includes the ability to search by therapy. Mastermind users can …
ANN ARBOR—Celsee Inc., the single-cell isolation and analysis developer, announced an agreement to provide scientists at China’s Kindstar Global, a medical testing service,with Celsee’s Genesis System for monitoring circulating tumor …
ANN ARBOR—Phenomics Health Inc., a University of Michigan research spinout that aims to increase the precision of pharmaceuticals by using individual people’s genetic information, announced it acquired patented pharmacometabolomic technology …
ANN ARBOR—The Ann Arbor-based genetic research software developer Genomenon Inc. announced the release of version 2.0 of its Mastermind software. The genomic search engine now includes the ability to search …
ANN ARBOR—Genomenon, the Ann Arbor-based developer of software for the analysis and interpretation of complex genomic data, announced a new partnership with Cogenica Ltd. that incorporates Genomenon’s Mastermind Genomic Search …
ROYAL OAK—OncoCell MDx Inc., a startup incubated at Harvard University to develop sophisticated cancer diagnosis from a simple blood sample, announced that it has raised $22.2 million in a Preferred …